Edwards Terri G, Vidmar Thomas J, Koeller Kevin, Bashkin James K, Fisher Chris
NanoVir, Kalamazoo, Michigan, United States of America.
PLoS One. 2013 Oct 2;8(10):e75406. doi: 10.1371/journal.pone.0075406. eCollection 2013.
DNA damage response (DDR) genes and pathways controlling the stability of HPV episomal DNA are reported here. We set out to understand the mechanism by which a DNA-binding, N-methylpyrrole-imidazole hairpin polyamide (PA25) acts to cause the dramatic loss of HPV DNA from cells. Southern blots revealed that PA25 alters HPV episomes within 5 hours of treatment. Gene expression arrays identified numerous DDR genes that were specifically altered in HPV16 episome-containing cells (W12E) by PA25, but not in HPV-negative (C33A) cells or in cells with integrated HPV16 (SiHa). A siRNA screen of 240 DDR genes was then conducted to identify enhancers and repressors of PA25 activity. Serendipitously, the screen also identified many novel genes, such as TDP1 and TDP2, regulating normal HPV episome stability. MRN and 9-1-1 complexes emerged as important for PA25-mediated episome destruction and were selected for follow-up studies. Mre11, along with other homologous recombination and dsDNA break repair genes, was among the highly significant PA25 repressors. The Mre11 inhibitor Mirin was found to sensitize HPV episomes to PA25 resulting in a ∼5-fold reduction of the PA25 IC50. A novel assay that couples end-labeling of DNA to Q-PCR showed that PA25 causes strand breaks within HPV DNA, and that Mirin greatly enhances this activity. The 9-1-1 complex member Rad9, a representative PA25 enhancer, was transiently phosphorylated in response to PA25 treatment suggesting that it has a role in detecting and signaling episome damage by PA25 to the cell. These results establish that DNA-targeted compounds enter cells and specifically target the HPV episome. This action leads to the activation of numerous DDR pathways and the massive elimination of episomal DNA from cells. Our findings demonstrate that viral episomes can be targeted for elimination from cells by minor groove binding agents, and implicate DDR pathways as important mediators of this process.
本文报道了控制人乳头瘤病毒(HPV)游离型DNA稳定性的DNA损伤反应(DDR)基因和途径。我们着手探究一种DNA结合型N-甲基吡咯-咪唑发夹聚酰胺(PA25)导致细胞中HPV DNA显著丢失的机制。Southern印迹显示,PA25在处理后5小时内改变了HPV游离型基因。基因表达阵列鉴定出许多DDR基因,这些基因在含有HPV16游离型基因的细胞(W12E)中被PA25特异性改变,但在HPV阴性细胞(C33A)或整合有HPV16的细胞(SiHa)中未被改变。随后对240个DDR基因进行了小干扰RNA(siRNA)筛选,以鉴定PA25活性的增强子和抑制子。意外的是,该筛选还鉴定出许多调节正常HPV游离型基因稳定性的新基因,如TDP1和TDP2。MRN和9-1-1复合物在PA25介导的游离型基因破坏中起重要作用,并被选作后续研究对象。Mre11以及其他同源重组和双链DNA断裂修复基因是PA25的高度显著抑制子。发现Mre11抑制剂米林可使HPV游离型基因对PA25敏感,导致PA25半数抑制浓度(IC50)降低约5倍。一种将DNA末端标记与定量聚合酶链反应(Q-PCR)相结合的新检测方法表明,PA25可导致HPV DNA链断裂,而米林可大大增强这种活性。9-1-1复合物成员Rad9是一种典型的PA25增强子,在PA25处理后会短暂磷酸化,这表明它在检测PA25对游离型基因的损伤并向细胞发出信号方面发挥作用。这些结果表明,靶向DNA的化合物进入细胞并特异性靶向HPV游离型基因。这种作用导致众多DDR途径的激活以及细胞中游离型DNA的大量消除。我们的研究结果表明,病毒游离型基因可被小沟结合剂靶向从细胞中消除,并且DDR途径是这一过程的重要介导者。